Condition: Hepatocellular Carcinoma (HCC) · Cholangiocarcinoma · Sponsor: Region Skane
The BILLIONSTARS study is a prospective, single arm observational study inviting patients diagnosed with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) who are to be recommended locoregional intervention by surgery, ablation or transarterial chemoembolization and/or antitumoral medical treatment. The aim is to investigate how tumor- and individual-related factors affect response to treatment. To this end, circulating tumor DNA, immune cells and various proteins will be analyzed in repeated blood samples taken before, during and after completion of systemic treatment. When applicable, analyses will also be performed on tumor tissue from resected tumors and biopsies, and in some cases also from autopsies
This description comes directly from the study's public registry record.
Karin Jirström, PhD, MD, professor · +46462220829 · karin.jirstrom@med.lu.se
Philip Falk, MD · +46709221850 · philip.falk@med.lu.se
Always discuss trial participation with your own doctor first.
| Onkologimottagning Central Hospital in Kristianstad | Kristianstad, Sweden | Recruiting |
| VE Onkologi Skåne University Hospital | Lund, Sweden | Recruiting |
| VO kirurgi och gastroenterologi Skåne University Hospital | Lund, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06877637